Brief: Imricor Medical Systems Completes Human Factors Study For All Devices In FDA Approval Pathway
18/09/2025 02:46
Sept 18 (Reuters) - Imricor Medical Systems Inc IMR.AX: SUCCESFULLY COMPLETES HUMAN FACTORS STUDY FOR ALL DEVICES IN FDA APPROVAL PATHWAY Further company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion